Literature DB >> 19218453

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Carole R Baskin1, Helle Bielefeldt-Ohmann, Terrence M Tumpey, Patrick J Sabourin, James P Long, Adolfo García-Sastre, Airn-E Tolnay, Randy Albrecht, John A Pyles, Pam H Olson, Lauri D Aicher, Elizabeth R Rosenzweig, Kaja Murali-Krishna, Edward A Clark, Mark S Kotur, Jamie L Fornek, Sean Proll, Robert E Palermo, Carol L Sabourin, Michael G Katze.   

Abstract

The mechanisms responsible for the virulence of the highly pathogenic avian influenza (HPAI) and of the 1918 pandemic influenza virus in humans remain poorly understood. To identify crucial components of the early host response during these infections by using both conventional and functional genomics tools, we studied 34 cynomolgus macaques (Macaca fascicularis) to compare a 2004 human H5N1 Vietnam isolate with 2 reassortant viruses possessing the 1918 hemagglutinin (HA) and neuraminidase (NA) surface proteins, known conveyors of virulence. One of the reassortants also contained the 1918 nonstructural (NS1) protein, an inhibitor of the host interferon response. Among these viruses, HPAI H5N1 was the most virulent. Within 24 h, the H5N1 virus produced severe bronchiolar and alveolar lesions. Notably, the H5N1 virus targeted type II pneumocytes throughout the 7-day infection, and induced the most dramatic and sustained expression of type I interferons and inflammatory and innate immune genes, as measured by genomic and protein assays. The H5N1 infection also resulted in prolonged margination of circulating T lymphocytes and notable apoptosis of activated dendritic cells in the lungs and draining lymph nodes early during infection. While both 1918 reassortant viruses also were highly pathogenic, the H5N1 virus was exceptional for the extent of tissue damage, cytokinemia, and interference with immune regulatory mechanisms, which may help explain the extreme virulence of HPAI viruses in humans.

Entities:  

Mesh:

Year:  2009        PMID: 19218453      PMCID: PMC2642661          DOI: 10.1073/pnas.0813234106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.

Authors:  T M Tumpey; X Lu; T Morken; S R Zaki; J M Katz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Pathology of fatal human infection associated with avian influenza A H5N1 virus.

Authors:  K F To; P K Chan; K F Chan; W K Lee; W Y Lam; K F Wong; N L Tang; D N Tsang; R Y Sung; T A Buckley; J S Tam; A F Cheng
Journal:  J Med Virol       Date:  2001-03       Impact factor: 2.327

4.  Differential response of respiratory dendritic cell subsets to influenza virus infection.

Authors:  Xueli Hao; Taeg S Kim; Thomas J Braciale
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

5.  Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets.

Authors:  Cheryl M Cameron; Mark J Cameron; Jesus F Bermejo-Martin; Longsi Ran; Luoling Xu; Patricia V Turner; Ran Ran; Ali Danesh; Yuan Fang; Pak-Kei M Chan; Nutan Mytle; Timothy J Sullivan; Tassie L Collins; Michael G Johnson; Julio C Medina; Thomas Rowe; David J Kelvin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

6.  Human influenza virus infection and apoptosis induction in human vascular endothelial cells.

Authors:  Makoto Sumikoshi; Koichi Hashimoto; Yukihiko Kawasaki; Hiroko Sakuma; Tatsuo Suzutani; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

7.  The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.

Authors:  Terrence M Tumpey; Kristy J Szretter; Neal Van Hoeven; Jacqueline M Katz; Georg Kochs; Otto Haller; Adolfo García-Sastre; Peter Staeheli
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

8.  H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.

Authors:  Lucy A Perrone; Julie K Plowden; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey
Journal:  PLoS Pathog       Date:  2008-08-01       Impact factor: 6.823

Review 9.  Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans.

Authors:  Christine Korteweg; Jiang Gu
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  204 in total

1.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Authors:  Ashley L Steed; George P Christophi; Gerard E Kaiko; Lulu Sun; Victoria M Goodwin; Umang Jain; Ekaterina Esaulova; Maxim N Artyomov; David J Morales; Michael J Holtzman; Adrianus C M Boon; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

2.  Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection.

Authors:  Hui Zeng; Claudia Pappas; Jessica A Belser; Katherine V Houser; Weiming Zhong; Debra A Wadford; Troy Stevens; Ron Balczon; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques.

Authors:  Tokiko Watanabe; Kyoko Shinya; Shinji Watanabe; Masaki Imai; Masato Hatta; Chengjun Li; Ben F Wolter; Gabriele Neumann; Anthony Hanson; Makoto Ozawa; Shinya Yamada; Hirotaka Imai; Saori Sakabe; Ryo Takano; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Mutsumi Ito; Satoshi Fukuyama; Eiryo Kawakami; Takeo Gorai; Heather A Simmons; Daniel Schenkman; Kevin Brunner; Saverio V Capuano; Jason T Weinfurter; Wataru Nishio; Yoshimasa Maniwa; Tatsuhiko Igarashi; Akiko Makino; Emily A Travanty; Jieru Wang; Anette Kilander; Susanne G Dudman; M Suresh; Robert J Mason; Olav Hungnes; Thomas C Friedrich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 4.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

5.  Differential impact of interferon regulatory factor 7 in initiation of the type I interferon response in the lymphocytic choriomeningitis virus-infected central nervous system versus the periphery.

Authors:  Jeanette Erbo Christensen; Christina Fenger; Shohreh Issazadeh-Navikas; Anna Krug; Peter Liljestrøm; Stanislas Goriely; Søren Riis Paludan; Bente Finsen; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

Review 6.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

7.  Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients.

Authors:  Tokiko Watanabe; Masaki Imai; Shinji Watanabe; Kyoko Shinya; Masato Hatta; Chengjun Li; Gabriele Neumann; Makoto Ozawa; Anthony Hanson; Gongxun Zhong; Satoshi Fukuyama; Eiryo Kawakami; Heather A Simmons; Daniel Schenkman; Kevin Brunner; Saverio V Capuano; Jason T Weinfurter; Anette Kilander; Susanne G Dudman; M Suresh; Olav Hungnes; Thomas C Friedrich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses.

Authors:  Wen-Chun Liu; Shih-Chang Lin; Yen-Ling Yu; Ching-Liang Chu; Suh-Chin Wu
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

9.  Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Alan G Goodman; Xinxia Peng; Sean C Proll; Victoria S Carter; Elizabeth R Rosenzweig; Kristy J Szretter; Jacqueline M Katz; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

10.  Estriol Reduces Pulmonary Immune Cell Recruitment and Inflammation to Protect Female Mice From Severe Influenza.

Authors:  Meghan S Vermillion; Rebecca L Ursin; Sarah E Attreed; Sabra L Klein
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.